source:[1] AtriCure treats first patients with dual PFA/RF system - MedTech Dive (https://www.medtechdive.com/news/AtriCure-PFA ...)[2] Targeted amplification of alternating electric fields using ferroelectric nanoparticles - Nature (https://www.nature.com/articles/s44385-025-00 ...)[3] Vesalio Receives FDA 510(k) Clearance of enVast, the First Stent-Based Coronary Thrombectomy Technology - BioSpace (https://www.biospace.com/press-releases/vesal ...)